# Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension

> **NCT00795262** · NA · COMPLETED · sponsor: **InVasc Therapeutics, Inc.** · enrollment: 23 (actual)

## Conditions studied

- Diabetes
- Hypertension

## Interventions

- **DRUG:** Quinapril (Accupril) plus Alpha Lipoic Acid
- **DRUG:** accupril, placebo
- **DRUG:** accupril, alpha lipoic acid

## Key facts

- **NCT ID:** NCT00795262
- **Lead sponsor:** InVasc Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2011-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795262, "Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00795262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*